With the uncertainty surrounding the midterm elections now behind us, traders can turn their attention back to what matters most: where the market is actually rewarding capital. One healthcare name has quietly built an impressive recovery, transitioning from a sharp early-year decline into a sustained uptrend marked by higher highs, higher lows, and a breakout to fresh 52-week highs in August. That strength has since carried the stock to new all-time highs, but the more telling development is happening beneath the surface: Thermo Fisher Scientific (TMO) has been consistently outperforming the S&P 500 since mid-May, with its relative strength ratio trending higher alongside the stock. In other words, TMO isn’t just moving higher; it’s gaining ground against the broader market, an important sign of underlying leadership that puts this healthcare name firmly on our radar.

💡 Wondering how some traders find options with big potential without committing huge amounts of capital? Our FREE Report focused on $100 options breaks down the key concepts in plain English. Click here to claim your FREE report! 🧠

With TMO trading around $706 per share, simply buying the stock requires a meaningful capital commitment, while purchasing an outright call option could also carry a hefty premium. An alternative is an in-the-money call debit spread, which provides bullish exposure through a defined-risk structure without requiring the same upfront investment as owning 100 shares or purchasing an expensive call outright. The specific spread we’re looking at requires just $695 to enter and offers 43.9% profit potential if TMO finishes expiration up, flat, or even down as much as 7.5% from the entry level, based on the hypothetical trade structure. For traders looking to participate in a strong trend while building some room for the stock to fluctuate, that’s a compelling way to approach the setup.

Finding attractive stocks is only half the equation; knowing exactly how to structure a trade around them is where the right strategy can make a difference. Our Optioneering Newsletter delivers multiple actionable trade ideas each week, complete with the technical reasoning, specific trade details, and additional strategy insights, and you can explore our flagship trading newsletter with a first-month trial for just $1. Get access today and see how we’re approaching the market’s opportunities inside the Optioneering Newsletter!

Wishing You the Best in Investing Success,

Blane Markham

Chief Trading Strategist

Have any questions? Email us at support@markhamtrading.com

*Trading incurs risk and some people lose money trading.